Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Graeme Wald currently holds 3,600 shares of Nexvet Biopharma plc (NVET), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Graeme Wald has been a net neutral trader of NVET stock. They have purchased $0 and sold $0 worth of shares.
Graeme Wald's most recent insider trade was on Jul 15, 2015, when they sold 3,600 shares at $0.13 per share.
Graeme Wald serves as Executive at Nexvet Biopharma plc (NVET). They have executed 3 insider transactions totaling $0 over their tenure at the company.
Graeme Wald holds the position of Executive at Nexvet Biopharma plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Graeme Wald has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Graeme Wald was on Jul 15, 2015, when they sold $468 worth of NVET shares. This transaction involved 3,600 shares at $0.13 per share.
Graeme Wald currently owns 3,600 shares of Nexvet Biopharma plc (NVET), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Graeme Wald's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Graeme Wald has 3 Form 4 filings on record as an insider at Nexvet Biopharma plc.
Set alerts for Graeme Wald and 40,000+ other insiders.